Heparin sodium APP
Heparin sodium APP is a biological therapy with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
Efficacy and Safety of Sodium Heparin in Patients
Efficacy and Safety of Sodium Heparin
Efficacy and Safety of Sodium Heparin in Patients (Cristália)
Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients
Clinical Trials (9)
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
Efficacy and Safety of Sodium Heparin in Patients
Efficacy and Safety of Sodium Heparin
Efficacy and Safety of Sodium Heparin in Patients (Cristália)
Efficacy and Safety of Sodium Heparin (Hipolabor) in Patients
Efficacy and Safety of Sodium Heparin (Eurofarma)
Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure.
Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients
All 9 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 9